Bristol Myers Deploys Anthropic AI for Drug Discovery
Bristol Myers Squibb is partnering with Anthropic to provide the Claude AI model to over 30,000 employees. The collaboration aims to accelerate drug development and manufacturing by leveraging agentic AI tools to unlock value from decades of siloed research data.
Xurve View
Insights:
Xurve View
BRISTOL-MYERS SQUIBB CO will deploy Anthropic's Claude AI model to 30,000 employees to accelerate drug discovery and delivery midday Wednesday. This move follows similar AI integrations by peers like ELI LILLY & CO to improve drug success rates. Investors are tracking whether AI can reduce the high costs and failure rates inherent in pharmaceutical research.
